½ÃÀ庸°í¼­
»óǰÄÚµå
1590642

´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå : À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ ¹× ¿ëµµº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Femoral Access Devices Market by Type (Nitinol Clip, Suture), End-User (Ambulatory Surgical Units, Hospitals & Care Providers), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀåÀº 2023³â¿¡ 17¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 19¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 11.16%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 36¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ëÅð°ñ Á¢±Ù ±â±â´Â ´ëÅðµ¿¸Æ ¶Ç´Â Á¤¸ÆÀ» ÅëÇÑ Ç÷°ü Á¢±ÙÀ» À§ÇÑ ÀÇ·á ½Ã¼ú¿¡ »ç¿ëµÇ´Â Áß¿äÇÑ µµ±¸·Î, Ç÷°üÁ¶¿µ¼ú, Ç÷°ü¼ºÇü¼ú, Ä«Å×ÅÍ Ä¡·á¿Í °°Àº Áø´Ü ¹× Ä¡·áÀû °³ÀÔÀ» ¿ëÀÌÇÏ°Ô ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ »ç¿ë ¹üÀ§´Â Áø´Ü¿ë¿¡¼­ º¹ÀâÇÑ ¼ö¼ú¿¡ À̸£±â±îÁö ´Ù¾çÇϸç, ÇÕº´Áõ °¨¼Ò, ½Ã¼ú Á¤È®µµ Çâ»ó, ȯÀÚ °á°ú °³¼±¿¡ ´ëÇÑ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ´Â ÁÖ·Î º´¿ø, ¼ö¼ú¼¾ÅÍ, Áø·á¼Ò µîÀ̸ç, ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ Æø³Ð°Ô Àû¿ëµÇ°í ÀÖ´Ù´Â Á¡ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÃÖ¼Òħ½ÀÀû ¼ö¼ú ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ÃÖ±Ù Á¤È®¼º°ú ¾ÈÀü¼ºÀ» º¸ÀåÇÏ´Â ±â¼ú ÅëÇÕÀº ´õ ¸¹Àº ÀáÀçÀû ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª ÷´Ü ÀåºñÀÇ ³ôÀº ºñ¿ë, ±î´Ù·Î¿î ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ¼ö¼ú ÇÕº´Áõ¿¡ µû¸¥ À§Çè µîÀÇ ¹®Á¦·Î ÀÎÇØ ½ÃÀå È®´ë°¡ Á¦Çѵǰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ ´ëÀÀÇϱâ À§ÇØ ºñ¿ë È¿À²ÀûÀÎ ±â±â °³¹ß, ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» À§ÇÑ ½º¸¶Æ® ±â¼ú°úÀÇ ÅëÇÕ, ±â±â Ž»öÀÇ Á¤È®µµ Çâ»ó°ú °°Àº À¯¸ÁÇÑ Çõ½Å ºÐ¾ß°¡ ÀÖ½À´Ï´Ù. »ýü Èí¼ö¼º ¼ÒÀç¿Í ȯÀÚÀÇ ÇØºÎÇÐÀû ±¸Á¶¿¡ ¸ÂÃá ¸ÂÃãÇü ±â±â ¿¬±¸´Â »ç¾÷ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇØ ÀÌÇØ°ü°èÀÚµéÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ, Çõ½Å ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃàÇϱâ À§ÇÑ ±ÔÁ¦ ÇöȲÀ» ÆÄ¾ÇÇÏ´Â µ¥ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. À¯¸ÁÇÑ Àü¸Á¿¡µµ ºÒ±¸Çϰí, ÀÌ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ±ÔÁ¦°¡ ½ÉÇÑ ½ÃÀåÀ̸ç, ¼º°øÀûÀÎ ½ÃÀå ÁøÀÔ°ú È®ÀåÀ» À§Çؼ­´Â ±â¼úÀû, Á¤Ã¥Àû À庮À» ±Øº¹ÇÏ´Â °ÍÀÌ °ü°ÇÀÔ´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ±³À° ¹× ÈÆ·ÃÀº äÅ÷üÀ» ³ôÀ̰í, º¯È­Çϴ ȯ°æ¿¡¼­ ±â¾÷À» Àü·«ÀûÀ¸·Î Æ÷Áö¼Å´×ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 175¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 19¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 36¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 11.16%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÇ÷°ü °ü·Ã Áúȯ Àα¸ Áõ°¡
    • ´õ Å« ½Ã½º »çÀÌÁî°¡ ÇÊ¿äÇÑ È¯ÀÚ³ª ¿ä°ñ Á¢±ÙÀÌ ¾î·Á¿î ȯÀÚµéÀÇ ¼±È£µµ Áõ°¡
    • ¼¼°è ºñ¸¸ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ·¹À̵ð¾ó ¾×¼¼½º ´ëºñ ³ôÀº ÇÕº´Áõ ¹ß»ý·ü ¹× Á¦Ç° ¸®ÄÝ ¹ß»ý·ü
  • ½ÃÀå ±âȸ
    • ´ëÅð°ñ Á¢±Ù ±â±â ½ÂÀÎ °Ç¼ö Áõ°¡
    • ÀÇ·áºñ Áõ°¡¿¡ µû¸¥ ½ÅÈï±¹ ¼ö¿ä Áõ°¡·Î ÀÎÇÑ ½ÅÈï°æÁ¦±¹ ¼ö¿ä Áõ°¡
  • ½ÃÀå °úÁ¦
    • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú ³ôÀº Àåºñ ºñ¿ë

Portre's Five Forces: ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå : À¯Çüº°

  • Nitinol Clip
  • Suture

Á¦7Àå ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú À¯´Ö
  • º´¿ø ¹× °£È£ ¼­ºñ½º Á¦°ø¾÷ü

Á¦8Àå ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå : ¿ëµµº°

  • ¼öÇ÷
  • Áø´Ü ¹× Å×½ºÆ®
  • ÀǾàǰ °ü¸®
  • ¼öºÐ ¹× ¿µ¾ç Åõ¿©

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ´ëÅð°ñ Á¢±Ù ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 3M Company
  • Abbott Laboratories
  • Advanced Vascular Dynamics by Semler Technologies, Inc.
  • AngioDynamics Inc
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Cardinal Health, Inc.
  • Cook Medical Inc
  • Medline Industries Inc
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Morris Innovative, Inc.
  • Smiths Medical PLC
  • Teleflex Incorporated
LSH

The Femoral Access Devices Market was valued at USD 1.75 billion in 2023, expected to reach USD 1.95 billion in 2024, and is projected to grow at a CAGR of 11.16%, to USD 3.68 billion by 2030.

Femoral access devices are critical tools used in medical procedures for vascular access through the femoral artery or vein, facilitating diagnostic and therapeutic interventions such as angiography, angioplasty, and catheterization. The scope of these devices spans from diagnostic applications to complex surgeries, highlighting their necessity in reducing complications, improving procedural accuracy, and enhancing patient outcomes. End-users predominantly include hospitals, surgical centers, and clinics, emphasizing their widespread application across various health care settings. The market growth is driven by factors like the rising prevalence of cardiovascular diseases, increasing elderly population, and advancements in minimally invasive surgical techniques. Recent technological integrations that ensure precision and safety further offer potential opportunities for growth. However, market expansion is constrained by challenges such as the high cost of advanced devices, stringent regulatory approvals, and the risks associated with procedural complications. Competing against these are the promising areas for innovation, which include the development of cost-effective devices, integration with smart technology for real-time monitoring, and increased accuracy in device navigation. Research into bioabsorbable materials and personalized devices tailored to patient anatomy can further drive business growth. To successfully capture these opportunities, stakeholders should focus on strategic partnerships with healthcare providers, investment in R&D, and navigating regulatory landscapes to reduce time-to-market for innovations. Despite its promising outlook, the market exists within a competitive and regulatory challenging nature, where overcoming technological and policy barriers is key for successful entry and expansion. Continual education and training for end-users can also enhance adoption rates, positioning companies strategically in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.75 billion
Estimated Year [2024] USD 1.95 billion
Forecast Year [2030] USD 3.68 billion
CAGR (%) 11.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Femoral Access Devices Market

The Femoral Access Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of cardiovascular related diseases among the population
    • Rising preference in cases that require larger sheath size or in patients with difficulty in radial access
    • Increasing prevalence of obesity worldwide
  • Market Restraints
    • High complication rates compared to radial access coupled with product recalls
  • Market Opportunities
    • Proliferation in the number of approval for femoral access devices
    • Emerging demand from developing economies with rising healthcare expenditure
  • Market Challenges
    • Lack of skilled professionals and high cost of the device

Porter's Five Forces: A Strategic Tool for Navigating the Femoral Access Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Femoral Access Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Femoral Access Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Femoral Access Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Femoral Access Devices Market

A detailed market share analysis in the Femoral Access Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Femoral Access Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Femoral Access Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Femoral Access Devices Market

A strategic analysis of the Femoral Access Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Femoral Access Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Vascular Dynamics by Semler Technologies, Inc., AngioDynamics Inc, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Cardinal Health, Inc., Cook Medical Inc, Medline Industries Inc, Medtronic PLC, Merit Medical Systems, Inc., Morris Innovative, Inc., Smiths Medical PLC, and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the Femoral Access Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Nitinol Clip and Suture.
  • Based on End-User, market is studied across Ambulatory Surgical Units and Hospitals & Care Providers.
  • Based on Application, market is studied across Blood Transfusion, Diagnostics & Testing, Drug Administration, and Fluid & Nutrition Administration.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cardiovascular related diseases among the population
      • 5.1.1.2. Rising preference in cases that require larger sheath size or in patients with difficulty in radial access
      • 5.1.1.3. Increasing prevalence of obesity worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High complication rates compared to radial access coupled with product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation in the number of approval for femoral access devices
      • 5.1.3.2. Emerging demand from developing economies with rising healthcare expenditure
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals and high cost of the device
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Femoral Access Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Nitinol Clip
  • 6.3. Suture

7. Femoral Access Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Units
  • 7.3. Hospitals & Care Providers

8. Femoral Access Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Blood Transfusion
  • 8.3. Diagnostics & Testing
  • 8.4. Drug Administration
  • 8.5. Fluid & Nutrition Administration

9. Americas Femoral Access Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Femoral Access Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Femoral Access Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Advanced Vascular Dynamics by Semler Technologies, Inc.
  • 4. AngioDynamics Inc
  • 5. B. Braun Melsungen AG
  • 6. Becton, Dickinson and Company
  • 7. Biotronik SE & Co. KG
  • 8. Cardinal Health, Inc.
  • 9. Cook Medical Inc
  • 10. Medline Industries Inc
  • 11. Medtronic PLC
  • 12. Merit Medical Systems, Inc.
  • 13. Morris Innovative, Inc.
  • 14. Smiths Medical PLC
  • 15. Teleflex Incorporated
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦